Where I see patients (2)
My reviews
Selected research
-
A Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction Cancers.
Cancer research communications
-
Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma.
JAMA surgery
-
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies.
Nature medicine
4.9